TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9535545

Group type: EXPERIMENTAL
Intervention: 4% pale sulfonated shale oil
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.5% hydrocortisone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle (active ingredient-free)
Number of subjects: 20
Study: 8845664

Group type: COMPARATOR
Intervention: Transfer Factor (TF), administered subcutaneously daily for 3 to 4 days during the acute phase, followed by maintenance dosages at 15-day intervals for the first 6 months and monthly thereafter.
Number of subjects: 20
Study: 2667687

Group type: EXPERIMENTAL
Intervention: Heater probe therapy (n = 20)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham treatment (n = 23)
Number of subjects: 43
Study: 334217

Group type: EXPERIMENTAL
Intervention: Nomifensine plus alcohol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo plus alcohol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nomifensine alone
Number of subjects: 9
Study: 30358697

Group type: EXPERIMENTAL
Intervention: Backward Running Training (BRT)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Forward Running Training (FRT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 43
Study: 29153730

Group type: EXPERIMENTAL
Intervention: Intranasal ketorolac (31.5 mg) with nitrous oxide/oxygen
Number of subjects: 102

Group type: COMPARATOR
Intervention: Intranasal saline placebo with nitrous oxide/oxygen
Number of subjects: 102
Study: 26293458

Group type: EXPERIMENTAL
Intervention: Verbal referrals only
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Verbal referrals + a tailored mailed reminder
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Verbal referrals + telephone health navigator
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Resolved problems
Number of subjects: 1090
Study: 24706338

Group type: EXPERIMENTAL
Intervention: Overall physical activity
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Work-related physical activity
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Organized sports
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Cumulative MET scores
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Sport-related physical activity in women
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Repeated traumatic events
Number of subjects: 652
Study: 23147972

Group type: EXPERIMENTAL
Intervention: Strictly enforced smoke-free car policy
Number of subjects: 981

Group type: COMPARATOR
Intervention: No smoke-free car policy
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Advice for smoke-free car
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Younger child and smoking ≤10 cigarettes per day
Number of subjects: 981
Study: 20889877

Group type: EXPERIMENTAL
Intervention: Iron (2 mg/kg/day) plus folate (5 mg/day)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Folate alone
Number of subjects: 82
Study: 17332786

Group type: EXPERIMENTAL
Intervention: Regular physical activity (e.g., brisk walking for at least 30 min daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: More vigorous physical exercise or resistance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unstructured and low-intensity physical activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement of maximal oxygen consumption
Number of subjects: 0
Study: 15964332

Group type: EXPERIMENTAL
Intervention: Cyclosporine C(0) levels
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Cyclosporine trough values
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Cyclosporine C(2) levels
Number of subjects: 334
Study: 11836038

Group type: EXPERIMENTAL
Intervention: Continuous combined therapy
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 10530227

Group type: COMPARATOR
Intervention: Miniplates for internal rigid fixation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Panfix lag screws for internal rigid fixation
Number of subjects: 60
Study: 7489174

Group type: EXPERIMENTAL
Intervention: Radical resection in patients with T4 tumors
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Extended resection
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Multivisceral resection
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control group (T3N0M0 and T3N1M0 lesions)
Number of subjects: 289
Study: 1827947

Group type: EXPERIMENTAL
Intervention: Estradiol and cyproterone acetate
Number of subjects: 99

Group type: COMPARATOR
Intervention: Estradiol and norethisterone acetate
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 99
Study: 7213581

Group type: EXPERIMENTAL
Intervention: 22 degrees temperature
Number of subjects: 9

Group type: COMPARATOR
Intervention: 28 degrees temperature
Number of subjects: 9
Study: 30633542

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg body mass)
Number of subjects: 10
Study: 27522590

Group type: EXPERIMENTAL
Intervention: Single-radius TKA (SR)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Multi-radius TKA (MR)
Number of subjects: 237
Study: 26183793

Group type: EXPERIMENTAL
Intervention: Continuous electrocardiographic monitoring with insertable cardiac monitors (ICM)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Single 24-hour Holter
Number of subjects: 168

Group type: COMPARATOR
Intervention: Single 30-day event recorder
Number of subjects: 168

Group type: COMPARATOR
Intervention: Quarterly 24-hour Holters
Number of subjects: 168

Group type: COMPARATOR
Intervention: Quarterly 7-day monitors
Number of subjects: 168

Group type: COMPARATOR
Intervention: All single external monitoring strategies
Number of subjects: 168

Group type: COMPARATOR
Intervention: Repetitive periodic monitoring strategies
Number of subjects: 168
Study: 24226492

Group type: EXPERIMENTAL
Intervention: Superficial cervical block with levobupivacaine before the surgical incision
Number of subjects: 64

Group type: COMPARATOR
Intervention: Morphine (standardized dose 30 minutes before the end of surgery)
Number of subjects: 64
Study: 21279704

Group type: EXPERIMENTAL
Intervention: NACT + radiotherapy (RT) + adjuvant chemotherapy (AC)
Number of subjects: 338

Group type: COMPARATOR
Intervention: CCRT + AC
Number of subjects: 338
Study: 19416133

Group type: EXPERIMENTAL
Intervention: Lansoprazole maintenance therapy for up to 82 months
Number of subjects: 195
Study: 17522560

Group type: EXPERIMENTAL
Intervention: Oral aripiprazole 10-15 mg/day (n = 153)
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Oral haloperidol 7.5-10 mg/day (n = 151)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Oral aripiprazole
Number of subjects: 448

Group type: COMPARATOR
Intervention: Oral haloperidol
Number of subjects: 448
Study: 15374803

Group type: EXPERIMENTAL
Intervention: Oral L-arginine therapy
Number of subjects: 0
Study: 11396750

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 93

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both heparins
Number of subjects: 93
Study: 9738746

Group type: EXPERIMENTAL
Intervention: Group I (prospective study with regular evaluations)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group II (non-prospective study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older cohort
Number of subjects: 0

Group type: COMPARATOR
Intervention: Younger cohort
Number of subjects: 0
Study: 8031159

Group type: EXPERIMENTAL
Intervention: MMC + UFT (A)
Number of subjects: 39

Group type: COMPARATOR
Intervention: MMC + 5-FU (B)
Number of subjects: 39
Study: 3363755

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Depth of 5 m and 36 m
Number of subjects: 24
Study: 29773326

Group type: EXPERIMENTAL
Intervention: Tremelimumab (1 mg/kg bodyweight) and durvalumab (20 mg/kg bodyweight) every 4 weeks for four doses, followed by maintenance intravenous durvalumab at the same dose and schedule for nine doses
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tremelimumab and durvalumab
Number of subjects: 40
Study: 27940181

Group type: EXPERIMENTAL
Intervention: MOVE+ intervention (multilevel individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: STAND+ intervention (MOVE+ intervention with sit-stand workstations)
Number of subjects: 720
Study: 26072382

Group type: EXPERIMENTAL
Intervention: Cognitive coping and relaxation intervention (CCRI)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Routine care (RC)
Number of subjects: 166
Study: 23046147

Group type: EXPERIMENTAL
Intervention: Desmopressin ODT 25μg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Desmopressin ODT 50μg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Desmopressin ODT 100μg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 16596358

Group type: EXPERIMENTAL
Intervention: BIAsp 30 (0.5 U/kg, split into 0.25 U/kg at 08.30 h and 0.25 U/kg at 20.30 h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: IGlarg (0.5 U/kg at 08.30 h)
Number of subjects: 12
Study: 14687254

Group type: EXPERIMENTAL
Intervention: Evidence-based cardiac care suggestions
Number of subjects: 706
Study: 10472344

Group type: EXPERIMENTAL
Intervention: Amifostine as a bolus injection (200 mg/m2 dissolved in 10 ml sodium chloride 0.9%)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Amifostine as a bolus injection
Number of subjects: 42
Study: 8709324

Group type: EXPERIMENTAL
Intervention: 30 mg urapidil for 4 weeks (group 2)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 30 mg urapidil for 2 weeks followed by 60 mg for 2 weeks (group 3)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo (group 1)
Number of subjects: 136
Study: 1876628

Group type: EXPERIMENTAL
Intervention: Clonidine (2 micrograms/kg, single i.v. dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6283753

Group type: EXPERIMENTAL
Intervention: 40 mg penbutolol (pure S‐form)
Number of subjects: 9

Group type: COMPARATOR
Intervention: 40 mg isopenbutolol (pure R‐form)
Number of subjects: 9
Study: 31738579

Group type: EXPERIMENTAL
Intervention: Suspected suicide attempt by a motor vehicle driver crashing into their vehicle
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Resulting crash from a suspected suicide attempt
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Personal knowledge of another driver experiencing a crash caused by a suicidal driver
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Fear of suicide attempts by crashing into their vehicle
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Anxiety about the possibility of a suicide attempt
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Challenges of avoiding a crash caused by a suicidal driver
Number of subjects: 863
Study: 28762437

Group type: EXPERIMENTAL
Intervention: 12-week intensive lifestyle intervention (ILI)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Education-only active comparator (AC)
Number of subjects: 140
Study: 25079477

Group type: EXPERIMENTAL
Intervention: Mg alginate plus simethicone
Number of subjects: 75

Group type: COMPARATOR
Intervention: Thickened formula
Number of subjects: 75

Group type: COMPARATOR
Intervention: Reassurance with lifestyle changes
Number of subjects: 75
Study: 22726703

Group type: EXPERIMENTAL
Intervention: Irrigating drains (red rubber catheters)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nonirrigating drains (Penrose drains)
Number of subjects: 46
Study: 21700623

Group type: EXPERIMENTAL
Intervention: Single-dose oseltamivir in morbidly obese patients
Number of subjects: 2

Group type: COMPARATOR
Intervention: Single-dose oseltamivir in control (non-obese) subjects
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Single-dose oseltamivir carboxylate in morbidly obese patients
Number of subjects: 2

Group type: COMPARATOR
Intervention: Single-dose oseltamivir carboxylate in control (non-obese) subjects
Number of subjects: 2
Study: 19363607

Group type: EXPERIMENTAL
Intervention: Bucillamine (Buc)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Salazosulfapyridine (SASP)
Number of subjects: 49
Study: 16739183

Group type: EXPERIMENTAL
Intervention: Primary therapist model (PTM)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Traditional treatment model (TTM)
Number of subjects: 111
Study: 15520323

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg PO
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11397030

Group type: EXPERIMENTAL
Intervention: Perforate Invagination (PIN) stripping
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional stripping
Number of subjects: 80
Study: 9237091

Group type: EXPERIMENTAL
Intervention: supervised home‐based exercise (higher or lower intensity)
Number of subjects: 269

Group type: COMPARATOR
Intervention: group‐based exercise program
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: short-term adherence predictors
Number of subjects: 269
Study: 8098243

Group type: EXPERIMENTAL
Intervention: 5 mg once-daily nebivolol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 10 mg once-daily nebivolol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 50 mg once-daily atenolol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 100 mg once-daily atenolol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 3632148

Group type: EXPERIMENTAL
Intervention: Activated charcoal with prebound aspirin
Number of subjects: 8
Study: 29710042

Group type: EXPERIMENTAL
Intervention: 1975 Japanese diet (JD)
Number of subjects: 32
Study: 26704028

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 14784

Group type: COMPARATOR
Intervention: Heparin + GPI
Number of subjects: 14784
Study: 26231856

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 390
Study: 23560584

Group type: EXPERIMENTAL
Intervention: Petrolatum jelly
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group (no petrolatum jelly)
Number of subjects: 213
Study: 21038951

Group type: EXPERIMENTAL
Intervention: Counterconditioning (repeated pairing of the cue with consumption of a highly disliked liquid, Polysorbate 20)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counterconditioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extinction (repeated presentation of the cue without chocolate consumption)
Number of subjects: 0
Study: 18164894

Group type: EXPERIMENTAL
Intervention: Tailored behavioral intervention
Number of subjects: 636

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 636
Study: 16731999

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/day
Number of subjects: 1501

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 1501
Study: 12714026

Group type: EXPERIMENTAL
Intervention: Bupropion SR (150 mg twice daily)
Number of subjects: 629

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 629
Study: 11091497

Group type: EXPERIMENTAL
Intervention: CD34+‐enriched autologous stem cell grafts
Number of subjects: 27

Group type: COMPARATOR
Intervention: Unmanipulated autologous stem cell grafts
Number of subjects: 27
Study: 8925996

Group type: EXPERIMENTAL
Intervention: Moderately differentiated adenocarcinomas (G2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Poorly differentiated adenocarcinomas
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (proliferative endometrium)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall study group (endometrial carcinoma)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sarcoma uteri patients
Number of subjects: 50
Study: 1360699

Group type: EXPERIMENTAL
Intervention: Wheat fibre (16 g day-1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ispaghula (16 g day-1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (during wash-out period)
Number of subjects: 10
Study: 6145726

Group type: EXPERIMENTAL
Intervention: Alprazolam (2 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Diazepam (15.8 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 48
Study: 29402522

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/rosuvastatin 20 mg
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/rosuvastatin 10 mg
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/rosuvastatin 5 mg
Number of subjects: 396

Group type: COMPARATOR
Intervention: Rosuvastatin 20 mg
Number of subjects: 396

Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg
Number of subjects: 396

Group type: COMPARATOR
Intervention: Rosuvastatin 5 mg
Number of subjects: 396
Study: 26965765

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (75 g per day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard carbohydrate counting
Number of subjects: 10
Study: 24899759

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment of Insomnia (BBTI)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Information-only Control (IC)
Number of subjects: 79
Study: 22190001

Group type: EXPERIMENTAL
Intervention: Testosterone therapy (gel)
Number of subjects: 38
Study: 20122739

Group type: EXPERIMENTAL
Intervention: Focal/grid photocoagulation
Number of subjects: 330
Study: 17441219

Group type: EXPERIMENTAL
Intervention: Midazolam and 1′-hydroxymidazolam determination using liquid chromatography-tandem mass spectrometry
Number of subjects: 0
Study: 16170182

Group type: COMPARATOR
Intervention: Dacarbazine 250 mg/m2 and cisplatin 30 mg/m2 combined with interferon‐alfa‐2b 10 x 10(6) U/m2 (arm A)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Dacarbazine 250 mg/m2 and cisplatin 30 mg/m2 combined with interferon‐alfa‐2b 10 x 10(6) U/m2 and IL-2 (arm B)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Dacarbazine, cisplatin, interferon‐alfa‐2b, and IL-2 (arm B)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Dacarbazine, cisplatin, and interferon‐alfa‐2b (arm A)
Number of subjects: 363
Study: 11994348

Group type: COMPARATOR
Intervention: Placebo (P) injections
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) and P (RT + P)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Weekly injections of testosterone (100 mg/wk)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RT and T (RT + T)
Number of subjects: 30
Study: 19667501

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0

Group type: COMPARATOR
Intervention: SSRIs (e.g., paroxetine, citalopram)
Number of subjects: 0
Study: 7486177

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sevoflurane with 60% N2O
Number of subjects: 21

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 21
Study: 2107135

Group type: EXPERIMENTAL
Intervention: Pentagastrin 1.5 micrograms/kg/h
Number of subjects: 8

Group type: COMPARATOR
Intervention: NaCl 0.9% or 0.1 M HCl (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pentagastrin infusion
Number of subjects: 8
Study: 84260

Group type: EXPERIMENTAL
Intervention: 1 g of vitamin C given daily for 28 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 0
Study: 29900553

Group type: EXPERIMENTAL
Intervention: ombitasvir/paritaprevir/ritonavir plus ribavirin for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks
Number of subjects: 60
Study: 27346063

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 24783926

Group type: EXPERIMENTAL
Intervention: Five-element music therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 50
Study: 23128580

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) training for primary care physicians
Number of subjects: 2965
Study: 19933120

Group type: EXPERIMENTAL
Intervention: Interactive, child-centred and family-based program
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 67
Study: 18482026

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 0
Study: 16885792

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 102

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 102
Study: 11470150

Group type: EXPERIMENTAL
Intervention: Interleukin (IL)‐10
Number of subjects: 0
Study: 9604591

Group type: EXPERIMENTAL
Intervention: HbS (study group)
Number of subjects: 310

Group type: COMPARATOR
Intervention: HbA (control group)
Number of subjects: 310
Study: 8002850

Group type: EXPERIMENTAL
Intervention: Cholesterol reduction treatment
Number of subjects: 50000
Study: 2544249

Group type: EXPERIMENTAL
Intervention: Dactinomycin (Actinomycin D) and Vincristine for 10 weeks
Number of subjects: 1439

Group type: COMPARATOR
Intervention: Dactinomycin (Actinomycin D) and Vincristine for 6 months
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Dactinomycin (Actinomycin D) + Vincristine +/− Adriamycin for 15 months
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy and Dactinomycin (Actinomycin D) + Vincristine + Adriamycin +/− Cyclophosphamide
Number of subjects: 1439
Study: 1586788

Group type: EXPERIMENTAL
Intervention: Breast shells
Number of subjects: 96

Group type: COMPARATOR
Intervention: No shells
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Hoffman's exercises
Number of subjects: 96

Group type: COMPARATOR
Intervention: No exercises
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Recommended shells
Number of subjects: 96

Group type: COMPARATOR
Intervention: Not recommended shells
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Exercises
Number of subjects: 96
Study: 580761

Group type: EXPERIMENTAL
Intervention: Rifampicin (oral dose, specific dosage not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing oral dose of rifampicin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rifampicin (oral dosage forms of the same nominal strength)
Number of subjects: 0
Study: 31981713

Group type: EXPERIMENTAL
Intervention: High-dose rifapentine with moxifloxacin for four months
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: High-dose rifapentine without moxifloxacin for four months
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Conventional six-month treatment regimen
Number of subjects: 2500